[High expression of ELFN1 is a prognostic biomarker and promotes proliferation and metastasis of colorectal cancer cells]
- PMID: 40673318
- PMCID: PMC12268922
- DOI: 10.12122/j.issn.1673-4254.2025.07.22
[High expression of ELFN1 is a prognostic biomarker and promotes proliferation and metastasis of colorectal cancer cells]
Abstract
Objectives: To explore the correlation of ELFN1 expression level with prognosis of colorectal cancer and its regulatory role in colorectal cancer cell proliferation and metastasis.
Methods: We analyzed the expression levels of ELFN1 across 33 cancer types using publicly available databases and identified differential genes related to ELFN1 in colorectal cancer. Gene function annotation and enrichment analysis were used to identify the involved signaling pathways. Logistic analysis, Kaplan-Meier analysis and Cox regression analysis were performed to evaluate the correlation between ELFN1 expression and clinicopathological parameters and survival of colorectal cancer patients. qPCR and Western blotting were used to validate the expression levels of ELFN1 in different colorectal cancer cell lines and tissues, and Transwell and EDU experiments were carried out to assess the effect of ELFN1 knockdown on biological behaviors of SW480 cells.
Results: ELFN1 was highly expressed in 14 cancers, and its expression was significantly higher in colon cancer tissues than in adjacent tissues. A high expression of ELFN1 mRNA was associated with a poorer overall survival of colorectal cancer patients. Cox regression analysis indicated that ELFN1 expression was an independent prognostic factor for overall survival of the patients. ELFN1 was significantly enriched in tumor metastasis and proliferation and participated in several tumor signaling pathways. The colon cancer cell lines showed significantly higher expression levels of ELFN1 than normal cells, ELFN1 knockdown obviously inhibited proliferation and migration of SW480 cells in vitro.
Conclusions: ELFN1 is overexpressed in colorectal cancer and is associated with poor clinical prognosis of the patients. A high ELFN1 expression is associated with malignant phenotypes of colorectal cancer and promotes cancer cell proliferation and metastasis, suggesting its potential as a prognostic biomarker for colorectal cancer.
目的: 探讨细胞外富含亮氨酸重复序列和纤连蛋白III型结构域的蛋白质1(ELFN1)在结肠癌中的表达、临床预后、基因功能、信号通路和生物学表型。方法: 运用R语言,通过公共数据库TCGA、GEO数据库分析33种癌谱ELFN1表达水平,并鉴定结肠癌中ELFN1的差异基因,通过基因功能注释和富集分析鉴定其相关信号通路;分析并评价ELFN1表达与临床病理特征的相关性;qPCR及Western blotting验证ELFN1在细胞株以及肠癌组织中的表达水平;Transwell、EDU实验分析ELFN1在SW480细胞的生物学表型。结果: ELFN1在14种肿瘤中高表达,结肠癌中ELFN1的表达高于癌周组织(P<0.001);临床特征与预后分析结果显示,ELFN1 mRNA高表达的患者OS较差;Cox回归分析显示,ELFN1表达是OS的独立预后因素(P<0.05);ELFN1在肿瘤转移增殖中显著富集,进一步GSEA分析识别了与之相关的肿瘤信号通路;实验分析结果显示,肠癌细胞系ELFN1的表达水平高于正常细胞(P<0.05);细胞功能实验显示,敲低ELFN1可阻止肠癌SW480细胞增殖和转移(P<0.05)。结论: ELFN1在结肠癌中异常高表达,并代表了不良的临床预后;并与肠癌增殖转移表型相关,提示ELFN1可能为结肠癌的预后标记物。.
Keywords: ECM signaling pathway; ELFN1; bioinformatics; clinical prognosis; colorectal cancer.
Conflict of interest statement
The authors declare no competing interests.
Figures







Similar articles
-
[Expression of SIPA1 in colorectal cancer and its impact on its biological behavior].Zhonghua Zhong Liu Za Zhi. 2025 Jul 23;47(7):657-668. doi: 10.3760/cma.j.cn112152-20240812-00338. Zhonghua Zhong Liu Za Zhi. 2025. PMID: 40692252 Chinese.
-
Expression of WNT10A in papillary thyroid carcinoma and its effect on cell proliferation, invasion, and metastasis.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 28;50(3):402-415. doi: 10.11817/j.issn.1672-7347.2025.240237. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025. PMID: 40628509 Chinese, English.
-
PLAGL2 as a prognostic biomarker and an EMT-promoting factor in PDAC.Sci Rep. 2025 Jul 14;15(1):25425. doi: 10.1038/s41598-025-09591-x. Sci Rep. 2025. PMID: 40659704 Free PMC article.
-
Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.Int J Mol Sci. 2024 May 15;25(10):5374. doi: 10.3390/ijms25105374. Int J Mol Sci. 2024. PMID: 38791414 Free PMC article.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical